Develops, manufactures and distributes vaccines and other pharmaceutical products
GlaxoSmithKline Plc operates as a science-led global healthcare company that researches and develops a broad range of innovative medicines and brands.
It operates in three primary areas of business: Pharmaceuticals, Vaccines and Consumer Healthcare.
The Pharmaceuticals business researches, develops and makes available medicines that treat a variety of serious and chronic diseases.
The Vaccines business produces pediatric and adult vaccines to prevent a range of infectious diseases including, hepatitis A and B, diphtheria, tetanus and whooping cough, measles, mumps and rubella, polio, typhoid, influenza and bacterial meningitis.
The Consumer Healthcare business markets a range of consumer health products based on scientific innovation.
The company was founded on December 6, 1999 and is headquartered in Brentford, United Kingdom.
Vote Quantity Float Company-owned shares Total Float
Shareholders GlaxoSmithKline plc (GSK - London Stock Exchange) GlaxoSmithKline plc (GSK - Nyse)
Name Equities % BlackRock Investment Management (UK) Ltd. 199,772,316
4.10% Legal & General Investment Management Ltd. 149,809,659
3.08% The Vanguard Group, Inc. 115,708,000
2.38% Norges Bank Investment Management 103,884,000
2.13% Capital Research & Management Co. (Global Investors) 102,630,000
2.11% Threadneedle Asset Management Ltd. 63,798,000
1.31% State Street Global Advisors Ltd. 62,119,000
1.28% Aberdeen Asset Investments Ltd. 61,528,000
1.26% Schroder Investment Management Ltd. 56,057,002
1.15% GlaxoSmithKline Employee Trust 52,734,605
Name Equities % Valuation
Aspen Pharmacare Holdings Limited (APNJ) 28,234,379 6.19% 614,637,302 USD Innoviva Inc (INVA) 32,005,260 28.1% 402,946,223 USD Theravance Biopharma Inc (TBPH) 9,644,807 25.1% 181,322,372 USD GlaxoSmithKline S.A.E. 76,161,378 91.2% 77,619,868 USD Dong-A Socio Holdings Co Ltd (000640) 409,693 8.58% 74,336,566 USD GlaxoSmithKline Consumer Nigeria PLC (GLAXOSM) 555,081,926 46.4% 69,673,883 USD Oncomed Pharmaceuticals Inc (OMED) 2,607,546 8.61% 26,362,290 USD Allergy Therapeutics plc (AGY) 10,118,000 1.72% 3,835,633 USD NeuroSearch A/S (NEUR) 1,950,500 7.94% 695,119 USD Response Genetics, Inc. (RGDXQ) 5,000,000 12.9% 5,000 USD
GlaxoSmithKline plc : Connections
The Council for Industry & Higher Education
Singapore Economic Development Board
Business Council for Britain
French Academy of Sciences
National Academy of Sciences
Longwood Fund Management LLC
National Theatre of Scotland
Council of Teaching Hospitals
American Academy of Arts & Sciences
Carnegie Hall Society, Inc.
Genelabs Technologies, Inc.
NYU Langone Medical Center
The University of Nottingham
The Trilateral Commission
The University of Texas Southwestern Medical Center
Southwestern Medical Foundation
Federal Reserve Bank of New York
Pharmaceutical Research & Manufacturers of America
The Natural History Museum
United Kingdom Department for Business, Innovation & Skills
European Federation of Pharmaceutical Industries & Assns
Harvey Nichols Group Ltd.
American Chemical Society
Biotechnology Industry Organization
Rockefeller Family Trust, Inc.
International AIDS Vaccine Initiative, Inc.
Massachusetts Institute of Technology
Company contact information 980 Great West road TW8 9GS Brentford, Greater London United Kingdom Phone : +44 (0)20 8047 5000 Fax : +44 (0)20 8047 7807 Internet : http://www.gsk.com
- London Stock Exchange, SETS
- Main Market
- FTSE 100 / FTSE 350, FTSE All-Share, FTSE Eurotop 100, Low Carbon 100 Europe, Stoxx Europe 50, Stoxx Global 200, Stoxx UK 50
- ISIN Code :
- Bloomberg Code :
- Reuters Code :
- Datastream Code :
© 2016 People , Fundamentals and Ownership
© 2016 Cofisem